This report contains market size and forecasts of Osimertinib in global, including the following market information:
Global Osimertinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Osimertinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Osimertinib companies in 2021 (%)
The global Osimertinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
40mg*30 Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Osimertinib include AstraZeneca, Incepta Pharmaceuticals Limited, Everest Pharmaceuticals, Beacon Pharma and Drug International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Osimertinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Osimertinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Osimertinib Market Segment Percentages, by Type, 2021 (%)
40mg*30 Tablets
80mg*30 Tablets
40mg*10 Tablets
80mg*10 Tablets
Global Osimertinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Osimertinib Market Segment Percentages, by Application, 2021 (%)
Locally Advanced NSCLC
Metastatic NSCLC
Other
Global Osimertinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Osimertinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Osimertinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Osimertinib revenues share in global market, 2021 (%)
Key companies Osimertinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Osimertinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Incepta Pharmaceuticals Limited
Everest Pharmaceuticals
Beacon Pharma
Drug International